CIK 0000872589
- Large accelerated filer
REGENERON PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- REGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NY
- Entity type
- Operating
- EIN
- 133444607
- Phone
- +1 914-847-7000
- Business address
- 777 OLD SAW MILL RIVER ROAD, TARRYTOWN, NY, 10591
- Former names
- REGENERON PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $59,162,329
- in 14 filings, $13.9M under 10b5-1 plans
Net −$59,162,329. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-06-29 | SING GEORGE L Director | Sale | −500 | $608.29 | $304K | 1,500 |
| 2020-06-29 | SING GEORGE L Director | Sale | −100 | $609.68 | $61K | 1,400 |
| 2020-06-29 | SING GEORGE L Director | Sale | −1,500 | $609.37 | $914K | 6,200 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −40 | $624.65 | $25K | 24,845 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −56 | $626.56 | $35K | 24,789 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −39 | $628.64 | $25K | 24,750 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −82 | $630.84 | $52K | 24,668 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −78 | $631.25 | $49K | 24,590 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −82 | $633.56 | $52K | 24,508 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −89 | $634.63 | $56K | 24,419 |
| 2020-06-23 | Landry Robert E EVP Finance CFO | Sale | −46 | $635.24 | $29K | 24,373 |
| 2020-06-22 | Landry Robert E EVP Finance CFO | Exercise or conversion | +8,900 | $555.67 | $4.9M | 33,273 |
| 2020-06-22 | Landry Robert E EVP Finance CFO | Shares withheld for taxes | −8,388 | $626.19 | $5.3M | 24,885 |
| 2020-06-22 | Landry Robert E EVP Finance CFO | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −8,900 | 20,000 | ||
| 2020-06-19 | Bassler Bonnie L Director | Exercise or conversion | +2,559 | $391.92 | $1.0M | 3,202 |
| 2020-06-19 | Bassler Bonnie L Director | Sale | −2,548 | $630.01 | $1.6M | 654 |
| 2020-06-19 | Bassler Bonnie L Director | Sale | −11 | $631.37 | $7K | 643 |
| 2020-06-19 | Bassler Bonnie L Director | Exercise or conversion · Non-Qualified Stock Option (right to buy) | −2,559 | 10,235 | ||
| 2020-06-16 | Fenimore Christopher R. VP Controller | Sale | −112 | $581.40 | $65K | 18,721 |
| 2020-06-16 | Fenimore Christopher R. VP Controller | Sale | −18 | $582.69 | $10K | 18,703 |
Page 141 of 181 · 3,603 trades